alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
FINANCIAL DATA SCHEDULE FOR OLYMPUS COMMUNICATIONS, L.P. FOR THE NINE MONTHS
ENDED SEPTEMBER 30, 1998.  INFORMATION IS ONLY INCLUDED FOR OLYMPUS
COMMUNICATIONS(A REGISTRANT) AND DOES NOT INCLUDE INFORMATION FOR OLYMPUS
CAPITAL CORP., WHICH HAS NO OPERATIONS.
</LEGEND>
<CIK> 0000861255
<NAME> OLYMPUS COMMUNICATIONS, L.P.
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-1998
<PERIOD-END>                               SEP-30-1998
<CASH>                                           3,672
<SECURITIES>                                         0
<RECEIVABLES>                                   12,375<F1>
<ALLOWANCES>                                         0<F1>
<INVENTORY>                                          0
<CURRENT-ASSETS>                                     0
<PP&E>                                         305,050<F2>
<DEPRECIATION>                                       0<F2>
<TOTAL-ASSETS>                                 843,919
<CURRENT-LIABILITIES>                                0
<BONDS>                                        730,970
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                             0
<OTHER-SE>                                   (131,747)
<TOTAL-LIABILITY-AND-EQUITY>                   843,919
<SALES>                                              0
<TOTAL-REVENUES>                               156,497
<CGS>                                                0
<TOTAL-COSTS>                                  126,976
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                              40,912
<INCOME-PRETAX>                               (15,181)
<INCOME-TAX>                                        84
<INCOME-CONTINUING>                           (15,265)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                  (15,265)
<EPS-PRIMARY>                                        0
<EPS-DILUTED>                                        0
<FN>
<F1>RECEIVABLES NET OF ALLOWANCE
<F2>PP&E NET OF DEPRECIATION
</FN>
        

</TABLE>
EXHIBIT 32.01

                  CERTIFICATION BY CHIEF EXECUTIVE OFFICER &
                            CHIEF FINANCIAL OFFICER

I, Michael Pacult, the Chief Executive Officer and Chief Financial Officer of
TriView Capital Management, Inc. as Managing Member of TriView Global Fund,
LLC, certify that (i) the Amendment No. 1 to Form 10-K for the year ended
December 31, 2006 of TriView Global Fund, LLC fully complies with the
requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934
and (ii) the information contained in the Amendment No. 1 to the Form 10-K for
the year ended December 31, 2006 fairly presents, in all material respects,
the financial condition and results of operations of TriView Global Fund, LLC.


TRIVIEW GLOBAL FUND, LLC
By:	TriView Capital Management, Inc., Managing Member



By: /s/ Michael Pacult
Michael Pacult
Chief Executive Officer &
Chief Financial Officer


Date:	July 3, 2007

<page>
### THE THIRTEENTH COURT OF APPEALS

13

- 14

- 00127

- CV

Rebecca R. Gonzalez

v. Mauro L. Reyna III
On Appeal from the 92nd District Court of Hidalgo County , Texas Trial Cause No. C

- 1682

- 09

- A

JUDGMENT THE THIRTEENTH COURT OF APPEALS, having considered this c ause on appeal, concludes that the judgment of the trial court should be AFFIRMED . The Court orders the judgment of the trial court AFFIRMED . Costs of the appeal are adjudged against appellant.
We further order this decision certified below for observanc e. July 2, 2015
UNITED STATES ENVIRONMENTAL PROTECTION AGENCY

DESIGN VALUE REPORT

Report Request ID: 1044019 Report Code: AMP480 Dec. 17, 2012

Selection Criteria Page 1

User ID: EFX

State County City Site Parameter POC AQCR UAR CBSA CSA

EPA

Region Method Duration Begin Date End Date

32

32

32

32

32

32

32

32

32

32

003

003

003

003

003

003

003

003

003

003

0043

0022

0071

0073

0075

0538

0540

0601

1019

2002

GEOGRAPHIC SELECTIONS

PROTOCOL SELECTIONS

Parameter

Classification Parameter Method Duration

DESIGN VALUE 44201

SELECTED OPTIONS

MERGE PDF FILES

QUARTERLY DATA IN WORKFILE

WORKFILE DELIMITER

SINGLE EVENT PROCESSING

USER SITE METADATA

Option Type Option Value

YES

NO

,

INCLUDE EVENTS

STREET ADDRESS

GLOBAL DATES

2012

Start Date End Date

2012

Tribal

Code

APPLICABLE STANDARDS

Standard Description

Ozone 8-Hour 2008
UNITED STATES ENVIRONMENTAL PROTECTION AGENCY

AIR QUALITY SYSTEM

PRELIMINARY DESIGN VALUE REPORT

Report Date: Dec. 17, 2012

Notes: 1. Computed design values are a snapshot of the data at the time the report was run (may not be all data for year). 

 2. Some PM2.5 24-hour DVs for incomplete data that are marked invalid here may be marked valid in the Official report due to additional analysis.

 3. Annual Values not meeting completeness criteria are marked with an asterisk ('*').

Page 1 of 1

Pollutant:

Standard Units:

Level:.075

NAAQS Standard: Ozone 8-Hour 2008

Statistic: Annual 4th Maximum

1

1

1

1

1

2

1

1

1

1

Poc

183

272

269

268

270

272

272

270

272

271

Valid

Days

 50

 74

 73

 73

 74

 74

 74

 74

 74

 74

Percent

Complete

 .076

 .077

 .078

 .078

 .079

 .074

 .073

 .077

 .077

 .076

4th

Max Cert

125

361

362

361

353

357

345

358

362

358

Valid

Days

 34

 99

 99

 99

 97

 98

 95

 98

 99

 98

Percent

Complete

 .070

 .078

 .077

 .077

 .077

 .073

 .073

 .070

 .074

 .072

4th

Max 

Y

Y

Y

Y

Y

Y

Y

Y

Y

Y

Cert

257

364

355

360

360

363

259

361

363

Valid

Days

 70

 100

 97

 99

 99

 99

 71

 99

 99

Percent

Complete

 .068

 .070

 .073

 .071

 .074

 .068

 .069

 .074

 .068

4th

Max Cert

 52

 91

 90

 90

 90

 91

 56

 81

 91

 91

Percent

Complete

 .071

 .075

 .076

 .075

 .076

 .071

 .073

 .072

 .075

 .072

Design

Value

N

Y

Y

Y

Y

N

N

N

Y

Y

D. V.

Validity

Ozone(44201)

Parts per million(007)

Site ID

|

|

|

|

|

|

|

|

|

|

|

|

32-003-0022

32-003-0043

32-003-0071

32-003-0073

32-003-0075

32-003-0538

32-003-0540

32-003-0601

32-003-1019

32-003-2002

REPORT INCLUDES MEASUREMENTS WITH EXCEPTIONAL EVENT FLAGS.

Design Value Year: 2012

STREET ADDRESS

2011 2010

State: Nevada

NE OF CITY-12101 HWY 

93/I15

4525 NEW FOREST DRIVE

7701 DUCHARME AVE

333 PAVILION CENTER DRIVE

6651 W. AZURE AVE

5483 CLUBHOUSE DRWINTERWOOD, LAS VEGAS

4250 Karen Ave

1005 INDUSTRIAL ROAD

T25S R59E S10

1301B EAST TONOPAH

2012

*

*

*

*

*

*

*

*

*

*

* *

*

3 - Year
### IN THE UNITED STATES COURT OF APPEALS FOR THE FIFTH CIRCUIT

No. 13

- 20600 Conference Calendar

UNITED STATES OF AMERICA,

Plaintiff

- Appellee

v.
MICHAEL MAURICE WILSON, JR., also known a s Blue, also known as Mikey

- Poo , Defendant

- Appellant

Appeal from the United States District Court for the Southern District of Texas USDC No. 4:11

- CR

- 61

- 10

Before DAVIS, ELROD, and COSTA, Circuit Judges. PER CURIAM: *
The attorney appointed to represent Michael Maurice Wilson, Jr., has moved for leave to withdraw and has filed a brief in accordance with Anders v. California , 386 U.S. 738 (1967), and United States v. Flores , 632 F.3d 229 (5th Cir. 2011). Wilson ha s not filed a response. We have reviewed counsel’s brief and the relevant portions of the record reflected therein. We concur with

* Pursuant to 5 TH C IR

. R. 47.5 , the court has determined that this opinion should not be published and is not precedent except under the limited circumstances set forth in 5 TH C IR

. R. 47.5.4. United States Court of Appeals Fifth Circuit 

### FILED February 24 , 2015 Lyle W. Cayce Clerk Case: 13-20600 Document: 00512945588 Page: 1 Date Filed: 02/24/2015No. 13

- 20600

counsel’s assessment that the appeal presents no nonfrivolous issue for appellate review. Accordingly, counsel’ s motion for leave to withdraw is GRANTED, counsel is excused from further responsibilities herein, and the APPEAL IS DISMISSED. See 5 TH C IR

. R. 42.2.

2 Case: 13-20600 Document: 00512945588 Page: 2 Date Filed: 02/24/2015
1/4/13 page of 

POST FOCUSEXPOSURE REPORT 

 Chemical ID: P-13-0077 Reviewer: Tobias/SS 

 

 

Results Table: Dose, Concentration, and Days Exceeded Results Summary 

Exposure Scenario1 Water Landfill Stack Air Fugitive Air 

Drinking Water Fish Ingestion 

ADR LADD ADR LADD 7Q104 

CC = 2 

PDM 

Days 

Exceede

d 

LADD ADR LADD ADR LADD 

Release 

activity(ies)2; 

exposure 

calculation(s)3 

mg/kg/day mg/kg/day mg/kg/day mg/kg/day μg/l # Days mg/kg/day mg/kg/day mg/kg/day mg/kg/day mg/kg/day 

max acute eco --- --- --- --- 5.47E+00 --- --- --- --- --- --- 

1 Exposure scenario titles consist of release activity followed by exposure calculation abbreviation. 

2 Release activities are from engineering report's Manufacturing (Mfg), Processing (Proc) and Use release 

activity labels. 

 Multiple release activities are combined in one exposure scenario if their releases occur at same location. 

3 Exposure calculations are Acute Dose Rate (ADR), Lifetime Average Daily Dose (LADD), and 

Probabilistic Dilution 

 Model (PDM). There may be one, two, or all three exposure calculations per exposure scenario. 

 CC is the aquatic concentration of concern. 

4 This column displays concentration values for the 7Q10 streamflow, which is defined as the average daily 

streamflow 

 of the seven consecutive days of lowest flow within a ten year period. 

 

Fate test recommendations?: (default is NA)
1/4/13 page of 

 POST FOCUSEXPOSURE REPORT 

Chemical ID: P-13-0077 Assessor: Tobias/SS 

ENVIRONMENTAL RELEASES 

 Scenario#:1 Number of Release Sites: 

 Release Activity: Max ADR 

 Release Description: WATER LANDFILL 

Non-sludge/Sludge 

STACK FUGITIVE 

Total Releases: 

 (kg/yr) (kg/yr) (kg/yr) (kg/yr) 

 

 Non-sludge/Sludge 

Release Days/yr: 

Per Site Release: 

 (kg/site/day) (kg/site/day) (kg/site/day) (kg/site/day) 

Remarks: 
1/4/13 page of 

POST FOCUSEXPOSURE REPORT 

 Chemical ID: P-13-0077 

SIC-CODE BASED HUMAN AND AQUATIC EXPOSURES TO SURFACE WATER RELEASES 

SCENARIO #: 1 Number of Sites: RELEASE ACTIVITY: Max 

ADR 

SIC-CODE DESCRIPTION: POTW's (All facilities) 

SIC-CODE (S): 4952 EXPOSED POPULATION: Adult 

WWT 

REMOVAL 

(%) 

RELEASE 

DAYS 

PRETREATMENT 

RELEASE 

(kg/site/day) 

POSTTREATMENT 

RELEASE 

(kg/site/day) 

DWT 

(%) BCF 

(L/kg) 

 0.00 0.00 

AQUATIC EXPOSURE ESTIMATES - SURFACE WATER 

PLANT 

TYPE 

% ILE 

FACILITY 

STREAM FLOW (MLD) STREAM CONC. (μg/l) 

Harmonic 

Mean 30Q5 7Q10 1Q10 

Harmonic 

Mean 30Q5 7Q10 1Q10 

ALL 50 125.56 44.02 26.80 22.53 4.62E-02 0.13 0.22 0.26 

ALL 10 11.11 1.94 1.06 0.96 0.52 2.99 5.47 6.04 

DRINKING WATER AND FISH INGESTION EXPOSURE ESTIMATES 

Exposure Units 

Drinking Water Results Drinking 

Water Units Fish Ingestion Results 

Fish 

Ingestion 

Units 

50% 10% 50% 10% 

Cancer 

LADDpot 9.87E-10 1.12E-08 mg/kg/day 0.00 0.00 mg/kg/day 

LADCpot 5.06E-08 5.72E-07 mg/L 0.00 0.00 mg/kg 

Acute 

ADRpot 1.10E-05 2.50E-04 mg/kg/day 0.00 0.00 mg/kg/day 

SIC Code Comments:
## SERVED: JUNE-27, 2012 U.S. DEPARTMENT OFTRANSPORTATION OFFICE OFHEARINGS

WASHINGTON, DC IN THEMATTER OF NV

### FASHION BEAUTY SUPPLY DISTRIBUTORS FAADOCKET NO. [TO BEASSIGNED] (Civil PenaltyAction) FDMS NO. FAA-2011-1123 

## POST HEARING BRIEFING SCHEDULE Thehearing was heldJune 19, 2012. Receipt ofthe transcript is anticipated shortly. WHEREFORE, the parties shall adhere to the following PostHearing Briefing Schedule: 1. Federal AviationAdministration (hereinafter "Complainant") shall file its Post-HearingBriefon orbefore July 27, 2012; 2. Nu Fashion (hereinafter "Respondent") shall file its Post-Hearing Briefon or beforeAugust 20, 2012; and 3. Complainant shall file its Rebuttal Brief, ifany, on orbefore August 27, 2012. 

# ..

# &~1ttgw2<~~ U.S. Administrative LawJudge Attachment(s)- ServiceList



### 1' SERVICE LIST ORIGINAL & ONE COPY Federal Aviation Administration 800 Independence Avenue, S.W. Washington, DC 20591 Attention: Hearing Docket Clerk, AGC-430 Wilbur Wright Building-Suite 2W1000 1 ONE COPY Ms. Gayle Chyu Nu Fashion Beauty SuppJy Distributors, Respondent 1366 Kingsland Avenue St. Louis, MO 63133 W. Beavis Schock, Respondent's Counsel 7777 Bonhomme Avenue, Suite 1300 St. Louis, MO 63105 TEL: 314-726-2322 FAJ<: 314-721-1698 Gayle E. Townsend, Complainant's Counsel Attorney, Office of Regional Counsel

Central Region, ACE-7 Federal Aviation Administration DOT Building

901 Locust, Room 506 Kansas City, MO 64106-264-1

TEL: 816-329-3766 FAJ<: 816-329-3771

The Honorable Richard C. Goodwin, Administrative Law Judge Office of Hearings, M-20 U.S. Department of Transportation 1200 New Jersey Avenue, S.E. (Ell-310) Washington, DC 20590 TEL: 202-366-2139 Attorney-Advisor 202-366-5121 Staff Assistant FAJ<: 202-366-7536

FDMS No. FAA-2011-1123 (Civil Penalty Action) ,, 1 Service was by U.S. Mail. For service in person or by expedited courier, use the following address: Federal Aviation Administration, 600 Independence Avenue, S.W., Wilbur Wright Building-Suite 2W1000, Washington, DC 20591; Attention: Hearing Docket Clerk, AGC-430. · -2-

·-·
**CERTIFICATION**




I,
      Pedro
      J. Lasanta, certify that:




1.
      I have
      reviewed this annual report on Form 10-KSB of Pharma-Bio Serv, Inc. ("Pharma-Bio
      Serv");




2.
      Based
      on my knowledge, this annual report does not contain any untrue statement of
      a
      material fact or omit to state a material fact necessary to make the statements
      made, in light of the circumstances under which such statements were made,
      not
      misleading with respect to the period covered by this annual
      report;




3.
      Based
      on my knowledge, the financial statements, and other financial information
      included in this annual report, fairly present in all material respects the
      financial condition, results of operations and cash flows of Pharma-Bio Serv
      as
      of and for, the periods presented in this annual report;




4.
      Pharma-Bio Serv's other certifying officer and I are responsible for
      establishing and maintaining disclosure controls and procedures (as defined
      in
      Exchange Act Rules 13a-15(e) and 15(d)-15(e) for Pharma-Bio Serv and
      have:




a.
      Designed such disclosure controls and procedures, or caused such disclosure
      controls and procedures to be designed under our supervision, to ensure that
      material information relating to Pharma-Bio Serv, including its consolidated
      subsidiaries, is made known to us by others within those entities, particularly
      during the period in which this annual report is being prepared;




b.
      Evaluated the effectiveness of Pharma-Bio Serv's disclosure controls and
      procedures and presented in this report our conclusions about the effectiveness
      of the disclosure controls and procedures, as of the end of the period covered
      by this report based on such evaluation; and




c.
      Disclosed in this report any change in Pharma-Bio Serv's internal control over
      financial reporting that occurred during its fourth fiscal quarter that has
      materially affected, or is reasonably likely to materially affect, Pharma-Bio
      Serv's internal control over financial reporting.




5.
      Pharma-Bio Serv's other certifying officer and I have disclosed, based on our
      most recent evaluation of internal control over financial reporting to
      Pharma-Bio Serv's auditors and the audit committee of Pharma-Bio Serv's board
      of
      directors (or persons performing the equivalent functions):




a.
      All
      significant deficiencies and material weaknesses in the design or operation
      of
      internal control over financial reporting which are reasonably likely to
      adversely affect Pharma-Bio Serv's ability to record, process, summarize and
      report financial information; and




b.
      Any
      fraud, whether or not material, that involves management or other employees
      who
      have a significant role in Pharma-Bio Serv's internal controls over financial
      reporting.





/s/
                Pedro J. LasantaPedro
                J. LasantaChief
                Financial Officer




Dated:
      January 31, 2008
**Exhibit 32**
   CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
    Each of the undersigned hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that this Quarterly Report on Form 10-Q for the quarter ended September 30, 2004 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, and the information contained in such report fairly presents, in all material respects, the financial condition and results of operations of the Company.
 
 This 12th day of November, 2004.
 /s/ David D. Stovall
 Chief Executive Officer
  /s/ Annette Banks
 Chief Financial Officer
Third Amendment to Supply Agreement



 Exhibit 10.118 
 THIRD AMENDMENT TO SUPPLY AGREEMENT 
 FOR BULK NARCOTICS RAW MATERIALS

 THIS THIRD AMENDMENT TO SUPPY AGREEMENT FOR BULK NARCOTICS RAW MATERIALS, originally made and entered into effective as
of July 1,1998 and amended on July 1, 2000 and again on July 1, 2006 (“SUPPLY AGREEMENT”), by and between ENDO PHARMACEUTICALS INC. (“BUYER”) and MALLINCKRODT LLC (formerly known as Mallinckrodt Inc.)
(“SELLER”), is made and entered between BUYER and SELLER effective on and as of July 1, 2011. 
 WHEREAS, as a
result of an internal reorganization, on and as of June 24, 2011, the name and organizational identity of Mallinckrodt Inc. was changed so that Mallinckrodt Inc., formerly a Delaware corporation, is now a limited liability company organized
under Delaware law and known as “Mallinckrodt LLC”, and 
 WHEREAS, the parties desire to amend the aforementioned
SUPPLY AGREEMENT for the third time in certain respects, 
 NOW, THEREFORE, the parties hereto agree as follows: 

 

	 	1.	Section 4 of the SUPPLY AGREEMENT shall be amended by deleting, in said Section 4, the reference to “two (2) years” and replacing it with a
reference to “twenty three (23) months”, with the intent and effect that either party will have until July 31, 2011 to provide written notice to the other party of its intent to let the SUPPLY AGREEMENT expire on June 30,
2013 without being renewed for an additional one (1) year period. 

  

	 	2.	Except as expressed amended herein, all of the other terms of the SUPPLY AGREEMENT, as amended, shall remain unchanged and in full force and effect.


 IN WITNESS WHEREOF, the parties hereto have executed this THIRD AMENDMENT TO SUPPLY AGREEMENT FOR BULK
NARCOTICS RAW MATERIALS effective as of the day and year first above written. 
  

							
	MALLINCKRODT LLC	  	ENDO PHARMACEUTICALS INC.
				
	By:	 	 /s/ NICK LITZSINGER
	  	By:	 	 /s/ JILL CONNELL

		 		  		 	
	Title:	 	 Global Director Bulk Narcotics
	  	Title:	 	 VP Generics Sourcing
II 

112TH CONGRESS 

2D SESSION S. 2777 

To extend the temporary suspension of duty on methyl sulfanilylcarbamate, 

sodium salt. 

IN THE SENATE OF THE UNITED STATES 

MAY 7, 2012 

Mr. CASEY introduced the following bill; which was read twice and referred 

to the Committee on Finance 

A BILL 

To extend the temporary suspension of duty on methyl 

sulfanilylcarbamate, sodium salt. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. METHYL SULFANILYLCARBAMATE, SODIUM 

4 SALT. 

5 (a) IN GENERAL.—Heading 9902.02.87 of the Har6 monized Tariff Schedule of the United States (relating to 

7 methyl sulfanilylcarbamate, sodium salt) is amended by 

8 striking the date in the effective period column and insert9 ing ‘‘12/31/2015’’. 


rfrederick on DSK6VPTVN1PROD with BILLS
2 

•S 2777 IS

1 (b) EFFECTIVE DATE.—The amendment made by 

2 subsection (a) applies to goods entered, or withdrawn from 

3 warehouse for consumption, on or after the 15th day after 

4 the date of the enactment of this Act. 

Æ 


rfrederick on DSK6VPTVN1PROD with BILLS
From: Hancy, Cindy Wang [ mailto:chancy@rti.org ]

Sent: Thursday, March 15, 2012 12:47 PM

To: Tracy, Brent

Cc: Reeves, David; Susan Fairchild

Subject: HAP Test Results Submitted to EPA

Mr. Tracy,

RTI is one of the contractors assisting EPA with the wool fiberglass NESHAP. After reviewing the

formaldehyde, phenol, and methanol results of Johns Manville facilities, we would like to verify whether

the testing below was completed while the bonded lines were running a HAP/Phenolic Binder.

JM Cleburne

– Testing performed 9/2010

Please feel free to contact me if you have any questions.

Regards,

Cindy Wang Hancy

RTI International

P.O. Box 12194

Research Triangle Park, NC 27709

Phone: (919) 541

- 6623

Fa x: (919) 316

- 3420
Exhibit 99.6

CERTIFICATION

Pursuant to 18 United States Code s. 1350

As adopted pursuant to

Section 906 of the SarbanesOxley Act of 2002

In connection with the Annual Report on
Form 40-F of Manulife Financial Corporation (the Company) for the year ended December 31, 2010, as filed with the Securities and Exchange Commission on the date hereof (the Report), the undersigned officer of the Company
certifies pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to his knowledge:



| | 1. | The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and
| | -- | ---------------------------------------------------------------------------------------------------------------------------------



| | 2. | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
| | -- | ----------------------------------------------------------------------------------------------------------------------------------------------------



|                                                            |  |               
|----------------------------------------------------------- |  | --------------
|Date:                                                       |  | March 18, 2011
|                                                           
|/s/ Michael w. Bell                                        
|Michael W. Bell                                            
|Senior Executive Vice President and Chief Financial Officer